Glycated Albumin May Be Superior to Fructosamine in Detecting Glucose Intolerance: The Africans in America Study

被引：0
|
作者：
Duong, Michelle T.
Thoreson, Caroline K.
Chung, Stephanie T.
Aldana, Paola C.
Ricks, Madia
Mabundo, Lilian S.
Sacks, David B.
Sumner, Anne E.
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1542-P
引用
收藏
页码：A401 / A402
页数：2
相关论文
共 50 条
  • [41] Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes
    Kaminski, Candice Y.
    Galindo, Rodolfo J.
    Navarrete, Jose E.
    Zabala, Zohyra
    Moazzami, Bobak
    Gerges, Amany
    McCoy, Rozalina G.
    Fayfman, Maya
    Vellanki, Priyathama
    Idrees, Thaer
    Peng, Limin
    Umpierrez, Guillermo E.
    DIABETES CARE, 2024, 47 (02) : 267 - 271
  • [42] Beta-cell failure rather than insulin resistance is the major cause of abnormal glucose tolerance in Africans: insight from the Africans in America study
    Ishimwe, M. C. Sage
    Wentzel, Annemarie
    Shoup, Elyssa M.
    Osei-Tutu, Nana H.
    Hormenu, Thomas
    Patterson, Arielle C.
    Bagheri, Hadi
    DuBose, Christopher W.
    Mabundo, Lilian S.
    Ha, Joon
    Sherman, Arthur
    Sumner, Anne E.
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [43] Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
    Vellanki, Priyathama
    Umpierrez, Guillermo E.
    DIABETES CARE, 2024, 47 (08) : e63 - e64
  • [44] Optimal glycated albumin cutoff value to diagnose diabetes in Korean adults: A retrospective study based on the oral glucose tolerance test
    Hwang, You-Cheol
    Jung, Chang Hee
    Ahn, Hong-Yup
    Jeon, Won Seon
    Jin, Sang-Man
    Woo, Jeong-taek
    Cha, Bong Soo
    Kim, Jae Hyeon
    Park, Cheol-Young
    Lee, Byung-Wan
    CLINICA CHIMICA ACTA, 2014, 437 : 1 - 5
  • [45] Clinical utility of 1-month postpartum random plasma glucose and glycated hemoglobin combined with pre-pregnancy body mass index for detecting postpartum glucose intolerance in Japanese women with gestational diabetes
    Sugiyama, Kazutoshi
    Saisho, Yoshifumi
    Kasuga, Yoshifumi
    Ochiai, Daigo
    Itoh, Hiroshi
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (12) : 2242 - 2246
  • [46] Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study
    Nathan, David M.
    McGee, Paula
    Steffes, Michael W.
    Lachin, John M.
    DIABETES, 2014, 63 (01) : 282 - 290
  • [47] Prepregnancy body mass index and glycated albumin in the third trimester may predict infant complications in gestational diabetes mellitus: a retrospective cohort study
    Sugawara, Daisuke
    Makita, Eishi
    Matsuura, Misa
    Sato, Hiroaki
    Kuwata, Tomoyuki
    Ichihashi, Ko
    DIABETOLOGY INTERNATIONAL, 2023, 14 (03) : 280 - 287
  • [48] Prepregnancy body mass index and glycated albumin in the third trimester may predict infant complications in gestational diabetes mellitus: a retrospective cohort study
    Daisuke Sugawara
    Eishi Makita
    Misa Matsuura
    Hiroaki Sato
    Tomoyuki Kuwata
    Ko Ichihashi
    Diabetology International, 2023, 14 : 280 - 287
  • [49] The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: A prospective study of women diagnosed with GDM during a period of universal GDM screening
    Bogdanet, Delia
    Castillo, Michelle T.
    Doheny, Helen
    Dervan, Louise
    Luque-Fernandez, Miguel A.
    Halperin, Jose
    O'Shea, Paula M.
    Dunne, Fidelma P.
    DIABETIC MEDICINE, 2023, 40 (09)
  • [50] Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267-271
    Wang, Ray
    Barmanray, Rahul D.
    Kyi, Mervyn
    Fourlanos, Spiros
    DIABETES CARE, 2024, 47 (08) : e61 - e62
12345